- Report
- October 2026
- 296 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 193 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 287 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 474 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 389 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 283 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 199 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 285 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 169 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 283 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 304 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 181 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 179 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 276 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 188 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 297 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 462 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 369 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 266 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more